APA (7th ed.) Citation

Julius Strauss. (2017). MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer. Global Journal of Cancer Therapy - Peertechz Publications. https://doi.org/10.17352/gjct.000019

Chicago Style (17th ed.) Citation

Julius Strauss. MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should We Be Chasing Colorectal Cancer or the KRAS Mutant Cancer. Global Journal of Cancer Therapy - Peertechz Publications, 2017. https://doi.org/10.17352/gjct.000019.

MLA (9th ed.) Citation

Julius Strauss. MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should We Be Chasing Colorectal Cancer or the KRAS Mutant Cancer. Global Journal of Cancer Therapy - Peertechz Publications, 2017. https://doi.org/10.17352/gjct.000019.